The objective of this double-blinded crossover study was to examine the effects of marine oil supplementation with high-dose eicosapentaenoic acid (EPA) on canine pruritic skin disease. Sixteen dogs that completed this study had clinical signs related to idiopathic pruritus, confirmed atopy and/or flea allergy. Each dog was randomly placed on one omega-3 fatty acid capsule (MVP: Meridian Veterinary Products, St. Augustine, FL, U.S.A.) which contained 1 ml of marine oil (180 mg EPA and 120 mg DHA) or one capsule containing 1 ml of corn oil (570 mg linoleic acid and 50 mg gamma linolenic acid) per 4.55 kg of body weight q 24 h for 6 weeks. After a 3-week washout period in which no supplement was given, each subject was crossed over to the other supplement for an additional 6 weeks. Dogs receiving marine oil showed a significant improvement in pruritus (P < O.OOl), self-trauma (P < 0.05) and coat character (P <0.01) over time. When compared to the corn oil control over time, marine oil supplementation significantly improved pruritus (P < 0.02), alopecia (P < 0.05) and coat character (P < 0.001). This study demonstrates the effectiveness of high doses of marine oil as an alternative anti-inflammatory for canine pruritic skin disease.

No abstract

The purpose of this randomized, single blinded clinical trial was to evaluate cytologically and clinically the efficacy of oral cephalexin alone and its combination with terbinafine or ketoconazole for the treatment of Malassezia dermatitis in dogs. Twenty-two client-owned dogs with Malassezia dermatitis completed the 3-week study. All received cephalexin (generic, 250 mg or 500 mg) at 22-30 mg kg(-1) twice daily. Eight dogs received terbinafine at 30 mg kg(-1) once daily and seven dogs received ketoconazole (generic, 200 mg) at 5-10 mg kg(-1) twice daily. The remaining seven dogs received cephalexin alone. At week 0 (visit 1) and week 3 (visit 2), mean yeast counts were determined from three affected areas using tape-strip cytology, a clinical index score (CIS) was assigned to the affected areas, and owners evaluated pruritus using a visual analogue scale. All groups showed reduction in mean yeast counts, CIS and pruritus. There was an 86.8%, 80.2% and 28.8% reduction in mean yeast counts from visit 1 to visit 2 for the terbinafine, ketoconazole and cephalexin-only groups, respectively. However, within treatment group comparisons a significant reduction in mean yeast count was only evident for the terbinafine (P < 0.002) and ketoconazole (P < 0.01) groups. Pruritus reduction was only significant for the terbinafine group. These preliminary results suggest that terbinafine should be further assessed for the treatment of canine Malassezia dermatitis.

The purpose of this study was to determine if the temperatures obtained using a veterinary infrared (IR) thermometer agreed with a digital rectal thermometer in a group of research cats, half of which had transient fevers. The thermometers were weakly correlated (r=0.62). The mean difference was 0.13 degrees F (0.07 degrees C), and the limits of agreement were 2.6 degrees F (1.43 degrees C) and -2.5 degrees F (-1.36 degrees C), which were unacceptable for clinical purposes. The results of this study indicate that, while the IR thermometer was easy to use, it cannot be used interchangeably with the rectal thermometer.

Cutaneous infection caused by rapidly growing mycobacteria is a relatively uncommon condition in cats, with variable response rates to surgical debulking and aggressive antibiotic therapy. To date, there have been very few case reports of this disease, especially in the United States. This study reviews a series of cases of cats with rapidly growing cutaneous mycobacterial infections from the south-eastern United States. A majority of the cats were spayed female domestic shorthairs. The median age at onset of clinical signs was 8 years. A majority of cats presented with characteristic lesions in multiple locations, and half of the cats had a known incidence of trauma preceding the development of clinical signs. Mycobacterium fortuitum was the most frequently cultured organism. Cats were treated with a variety of antibiotics for a median of 12 months, and half of them underwent surgical debulking of infected tissue. Five out of the 10 cats reached clinical resolution, while five did not. Those that did resolve required a median of 7 months of antibiotic treatment following diagnosis, and had been lesion-free for a median of 24 months at the time this study was completed. Those that did not resolve were treated for a median of 20 months following diagnosis, two of which were still being treated at the time this study was completed.